Citations

Mayo Clinic

Showing 10 of 108602 citations.

Extratesticular Scrotal Masses and Pseudomasses
Smith, Mathew V. , Young, Scott W. , Patel, Bhavik N. , Yano, Motoyo , Fananapazir, Ghaneh , Smith, Mathew , Young, Scott W , Patel, Bhavik , Fananapazir, Ghaneh , Tan, Nelly

RadioGraphics | April 27, 2023 | Volume: 43 | Issue: 5 | Pages: No page available

10.1148/rg.220080 | PMID 37104123 Get It

Impact of Artificial Intelligence System and Volumetric Density on Risk Prediction of Interval, Screen-Detected, and Advanced Breast Cancer
Vachon, Celine M. , Scott, Christopher G. , Norman, Aaron D. , Khanani, Sadia, Jensen, Matthew R. , Hruska, Carrie B. , Brandt, Kathleen R. , Winham, Stacey J. , Kerlikowske, Karla , Khanani, Sadia A, Winham, Stacey J , Hruska, Carrie B , Scott, Christopher , Norman, Aaron D , Kerlikowske, Karla M , Vachon, Celine M.

Journal of Clinical Oncology | April 27, 2023 | Volume: 41 | Issue: 17 | Pages: 3172-3183

10.1200/jco.22.01153 | PMID 37104728 Get It

PURPOSE Artificial intelligence (AI) algorithms improve breast cancer detection on mammography, but their contribution to long-term risk prediction for advanced and interval cancers is unknown. METHODS We identified 2,412 women with invasive breast cancer and 4,995 controls matched on age, race, and date of mammogram, from two US mammography cohorts, who had two-dimensional full-field digital mammograms performed 2-5.5 years before cancer diagnosis. We assessed Breast Imaging Reporting and Data System density, an AI malignancy score (1-10), and volumetric density measures. We used conditional logistic regression to estimate odds ratios (ORs), 95% CIs, adjusted for age and BMI, and C-statistics (AUC) to describe the association of AI score with invasive cancer and its contribution to models with breast density measures. Likelihood ratio tests (LRTs) and bootstrapping methods were used to compare model performance. RESULTS On mammograms between 2-5.5 years prior to cancer, a one unit increase in AI score was associated with 20% greater odds of invasive breast cancer (OR, 1.20; 95% CI, 1.17 to 1.22; AUC, 0.63; 95% CI, 0.62 to 0.64) and was similarly predictive of interval (OR, 1.20; 95% CI, 1.13 to 1.27; AUC, 0.63) and advanced cancers (OR, 1.23; 95% CI, 1.16 to 1.31; AUC, 0.64) and in dense (OR, 1.18; 95% CI, 1.15 to 1.22; AUC, 0.66) breasts. AI score improved prediction of all cancer types in models with density measures ( P LRT values < .001); discrimination improved for advanced cancer (ie, AUC for dense volume increased from 0.624 to 0.679, Δ AUC 0.065, P = .01) but did not reach statistical significance for interval cancer. CONCLUSION AI imaging algorithms coupled with breast density independently contribute to long-term risk prediction of invasive breast cancers, in particular, advanced cancer.
P erspective : Teenagers and the sleep paradox
Ramar, Sreya, Lloyd, Robin M.

Journal of Clinical Sleep Medicine | April 27, 2023 | Volume: 19 | Issue: 8 | Pages: 1569-1571

10.5664/jcsm.10636 | PMID 37185050 Get It

Are clinical trials for insomnia recruiting real-world patients?
Golebiowski, Raphael, Kolla, Bhanu Prakash , Mansukhani, Meghna P.

Journal of Clinical Sleep Medicine | April 27, 2023 | Volume: 19 | Issue: 8 | Pages: 1553-1555

10.5664/jcsm.10640 | PMID 37185063 Get It

Risk Factors for Stiffness Requiring Intervention After Ream-and-Run Arthroplasty
Schiffman, Corey J. , Jurgensmeier, Kevin , Yao, Jie , Wu, John , Whitson, Anastasia J. , Jackins, Sarah E. , Matsen, Frederick A. , Hsu, Jason E. , Yao, Jie J , Wu, John C , Jurgensmeier, Kevin

JBJS Open Access | April 27, 2023 | Volume: 8 | Issue: 2 | Pages: No page available

10.2106/jbjs.oa.22.00104 | PMID 37123506 Get It

Background: Ream-and-run arthroplasty can improve pain and function in patients with glenohumeral arthritis while avoiding the complications and activity restrictions associated with a prosthetic glenoid component. However, stiffness is a known complication after ream-and-run arthroplasty and can lead to repeat procedures such as a manipulation under anesthesia (MUA) or open surgical revision. The objective of this study was to determine risk factors associated with repeat procedures indicated for postoperative stiffness after ream-and-run arthroplasty. Methods: We conducted a retrospective review of our shoulder arthroplasty database to identify patients who underwent ream-and-run arthroplasty and determined which patients underwent subsequent repeat procedures (MUA and/or open revision) indicated for postoperative stiffness. The minimum follow-up was 2 years. We collected baseline demographic information and preoperative and 2-year patient-reported outcome scores and analyzed preoperative radiographs. Univariate and multivariate analyses determined the factors significantly associated with repeat procedures to treat postoperative stiffness. Results: There were 340 patients who underwent ream-and-run arthroplasty. The mean Simple Shoulder Test (SST) scores for all patients improved from 5.0 ± 2.4 preoperatively to 10.2 ± 2.6 postoperatively (p < 0.001). Twenty-six patients (7.6%) underwent open revision for stiffness. An additional 35 patients (10.3%) underwent MUA. Univariate analysis found younger age (p = 0.001), female sex (p = 0.034), lower American Society of Anesthesiologists (ASA) class (p = 0.045), posterior decentering on preoperative radiographs (p = 0.010), and less passive forward elevation at the time of discharge after ream-and-run arthroplasty (p < 0.001) to be significant risk factors for repeat procedures. Multivariate analysis found younger age (p = 0.040), ASA class 1 compared with class 3 (p = 0.020), and less passive forward elevation at discharge (p < 0.001) to be independent risk factors for repeat procedures. Of the patients who underwent open revision for stiffness, 69.2% had multiple positive cultures for Cutibacterium. Conclusions: Younger age, ASA class 1 compared with class 3, and less passive forward elevation in the immediate postoperative period were independent risk factors for repeat procedures to treat postoperative stiffness after ream-and-run arthroplasty. Level of Evidence: Prognostic Level III . See Instructions for Authors for a complete description of levels of evidence.
Minimal Access Percutaneous Depressor Anguli Oris Myectomy and Terminal Neurolysis for Facial Paralysis Patients with Aberrant Reinnervation Syndrome
Dey, Jacob K. , Boahene, Kofi , Boahene, Kofi D O , Dey, Jacob K

Facial Plastic Surgery & Aesthetic Medicine | April 27, 2023 | Volume: 25 | Issue: 4 | Pages: 365-366

10.1089/fpsam.2023.0033 | PMID 37103990 Get It

Utility and Recommendations for the Use of Multiplex Molecular Gastrointestinal Pathogen Panels
Hata, D. Jane , Powell, Eleanor A. , Starolis, Meghan W.

The Journal of Applied Laboratory Medicine | April 27, 2023 | Volume: 8 | Issue: 6 | Pages: 1148-1159

10.1093/jalm/jfad009 | PMID 37102500 Get It

Abstract Background Many molecular gastrointestinal pathogen panels (GIPs) are Food and Drug Administration (FDA) cleared but it is still unclear how to best utilize these new diagnostic tools. GIPs are highly sensitive and specific, simultaneously detect multiple pathogens in one reaction, and can shorten the overall time of diagnosis for infectious gastroenteritis but are also expensive with relatively poor insurance reimbursement. Content In this review, we take a comprehensive approach to discuss issues with utilization of GIPs from a physician perspective, and implementation from a laboratory perspective. The information presented is to assist physicians in deciding on appropriate use of GIPs in diagnostic algorithms for their patients, and to provide information to laboratories that may be considering the addition of these powerful diagnostic assays to their test menu. Some of the important topics discussed are inpatient vs outpatient use, the appropriate panel size and organisms to include, interpretation of results, laboratory validation, and reimbursement. Summary The information in this review provides clear guidance to both clinicians and laboratories in deciding the best use of GIPs for a specific patient population. While this technology provides many benefits over traditional methods, it can also complicate result interpretation and comes with a high cost, which necessitates the need for use recommendations.
Endocarditis, invasive dental procedures, and antibiotic prophylaxis efficacy in US Medicaid patients
Thornhill, Martin H. , Gibson, Teresa B. , Yoon, Frank, Prendergast, Bernard , Lockhart, Peter B. , O’Gara, Patrick T. , O'Gara, Patrick T , Thornhill, M H , Dayer, Mark , Baddour, Larry M.

Oral Diseases | April 27, 2023 | Volume: 30 | Issue: 3 | Pages: 1591-1605

10.1111/odi.14585 | PMID 37103475 Get It

Abstract Objective Antibiotic prophylaxis is recommended before invasive dental procedures to prevent endocarditis in those at high risk, but supporting data are sparse. We therefore investigated any association between invasive dental procedures and endocarditis, and any antibiotic prophylaxis effect on endocarditis incidence. Subjects and Methods Cohort and case‐crossover studies were performed on 1,678,190 Medicaid patients with linked medical, dental, and prescription data. Results The cohort study identified increased endocarditis incidence within 30 days of invasive dental procedures in those at high risk, particularly after extractions (OR 14.17, 95% CI 5.40–52.11, p < 0.0001) or oral surgery (OR 29.98, 95% CI 9.62–119.34, p < 0.0001). Furthermore, antibiotic prophylaxis significantly reduced endocarditis incidence following invasive dental procedures (OR 0.20, 95% CI 0.06–0.53, p < 0.0001). Case‐crossover analysis confirmed the association between invasive dental procedures and endocarditis in those at high risk, particularly following extractions (OR 3.74, 95% CI 2.65–5.27, p < 0.005) and oral surgery (OR 10.66, 95% CI 5.18–21.92, p < 0.0001). The number of invasive procedures, extractions, or surgical procedures needing antibiotic prophylaxis to prevent one endocarditis case was 244, 143 and 71, respectively. Conclusions Invasive dental procedures (particularly extractions and oral surgery) were significantly associated with endocarditis in high‐risk individuals, but AP significantly reduced endocarditis incidence following these procedures, thereby supporting current guideline recommendations.
Effect of peripartum Clostridioides difficile infection on pregnancy and neonatal outcomes: an observational study
Saha, Srishti , Pardi, Ryan, Theiler, Regan N. , Pardi, Darrell S. , Khanna, Sahil , Theiler, Regan

Therapeutic Advances in Gastroenterology | April 27, 2023 | Volume: 16 | Issue: No issue available | Pages: No page available

10.1177/17562848231170479 | PMID 37124369 Get It

Background: The incidence of Clostridioides difficile infection (CDI) in peripartum women is rising, but limited data on its effect on maternal and neonatal outcomes are available. Objective: To study the effect of peripartum CDI on pregnancy and neonatal outcomes. Design: Retrospective cohort study. Methods: Patients with peripartum CDI 12 weeks before pregnancy through 6 weeks postpartum (January 1996–February 2018) were matched with controls (peripartum women without CDI) 1:1 by age, year of delivery, and prior pregnancies. McNemar’s test and conditional logistic regression were used to analyze the effect of CDI on pregnancy and neonatal outcomes (complications, mode of delivery). p < 0.05 was considered statistically significant. Results: Overall, 101 cases and 100 controls (1997–2018) were included; median age 27 (range, 20–41) years. Timing of CDI was as follows: pre-pregnancy: 15.8% ( n = 16), during pregnancy: 51.5% ( n = 52), and postpartum: 32.7% ( n = 33). The commonest risk factor was outpatient/emergency room visits. Pregnancy and neonatal outcomes were analyzed for 67 matched pairs with CDI before or during pregnancy. Cases had higher odds of cesarean delivery ( p = 0.02) and lower odds of Group B Streptococcus (GBS) infection/colonization ( p = 0.03). Odds of cesarean delivery remained high after controlling for labor arrest disorders [odds ratio (OR): 17.23 (95% confidence interval (CI), 2.19–543.19; p = 0.004)]; odds of GBS remained low after controlling for antibiotic use (OR: 0.25, 95% CI, 0.04–0.99; p = 0.049). Neonatal outcomes were similar in cases and controls. CDI treatment did not affect treatment-related or delivery outcomes. Conclusion: Peripartum CDI was associated with higher odds of cesarean delivery and lower odds of GBS infections. Larger studies exploring the effect of CDI on pregnancy and neonatal outcomes are needed.
The natural history of histological changes in microscopic colitis
Sehgal, Kanika , Tome, June , Kamboj, Amrit K. , Dierkhising, Ross , Pardi, Darrell S. , Khanna, Sahil , Tome, June

Therapeutic Advances in Gastroenterology | April 27, 2023 | Volume: 16 | Issue: No issue available | Pages: No page available

10.1177/17562848231168237 | PMID 37124370 Get It

Background: Microscopic colitis (MC) causes chronic diarrhea. It has two histologic subtypes: lymphocytic colitis (LC) and collagenous colitis (CC). Little is known about the natural progression of disease with time and with treatment. Objectives: We aimed to assess histological changes over time. Design: We designed a retrospective study including adults diagnosed with MC from January 1992 to January 2020 at Mayo Clinic. Methods: Pathology reports were reviewed until 31 October 2020. Histological assessments at least 8 weeks apart were considered as adequate follow-up. Histological change from one subtype to the other and resolution were tracked with univariate and multivariable Cox proportional hazards models. Results: Overall, 416 patients with a median age at diagnosis of 63.9 years with >1 histopathological assessment were identified. Histology at initial diagnosis was CC in 218 (52.4%) patients and LC in 198 (47.6%). No medications were associated with a histological change. However, histological resolution was more likely with the use of aspirin [hazard ratio (HR): 2.10, 95% confidence interval (CI): 1.34–3.31, p = 0.001) and proton-pump inhibitors (PPIs; HR: 2.01, 95% CI: 1.34–3.02, p = 0.001). Histological resolution was more likely with budesonide treatment (HR: 1.86, 95% CI: 1.16–3.00, p = 0.010) and less likely with mesalamine (HR: 0.40, 95% CI: 0.19–0.83, p = 0.014), compared to medications such as prednisone, loperamide, and bismuth. Patients with CC were less likely to change their histology compared to patients with LC (HR: 0.24, 95% CI: 0.14–0.42, p < 0.001). There was no difference in histological resolution between the two subtypes (HR: 0.70, 95% CI: 0.47–1.05, p = 0.084). Conclusion: Patients with LC have a higher chance of changing their histology as compared to CC. However, histological resolution was associated with the use of PPIs and aspirin, and treatment with budesonide.